Literature DB >> 18626493

Glomerular filtration: the charge debate charges ahead.

Jeffrey H Miner1.   

Abstract

The concept that the glomerular filtration barrier exhibits charge selectivity is a basic tenet of renal physiology. Heparan sulfate is a major contributor of glomerular anionic charge. In a new study, prevention of podocytes from synthesizing heparan sulfate, via mutation of Ext1, causes only mild, statistically insignificant albuminuria, despite dramatic alterations in glomerular anionic charge.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18626493     DOI: 10.1038/ki.2008.260

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

Review 1.  Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?

Authors:  Caroline B Marshall
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-31

Review 2.  The glomerulus--a view from the outside--the podocyte.

Authors:  Huifang Cheng; Raymond C Harris
Journal:  Int J Biochem Cell Biol       Date:  2010-06-11       Impact factor: 5.085

Review 3.  New insights into human minimal change disease: lessons from animal models.

Authors:  Sumant S Chugh; Lionel C Clement; Camille Macé
Journal:  Am J Kidney Dis       Date:  2011-10-05       Impact factor: 8.860

4.  Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.

Authors:  Sanjeev Sethi; Benjamin J Madden; Hanna Debiec; M Cristine Charlesworth; LouAnn Gross; Aishwarya Ravindran; Amber M Hummel; Ulrich Specks; Fernando C Fervenza; Pierre Ronco
Journal:  J Am Soc Nephrol       Date:  2019-05-06       Impact factor: 10.121

Review 5.  Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2013-03-08       Impact factor: 3.714

6.  Efficient expression of single chain variable fragment antibody against paclitaxel using the Bombyx mori nucleopolyhedrovirus bacmid DNA system and its characterizations.

Authors:  Gorawit Yusakul; Seiichi Sakamoto; Hiroyuki Tanaka; Satoshi Morimoto
Journal:  J Nat Med       Date:  2016-03-03       Impact factor: 2.343

7.  Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered.

Authors:  Antonio V Gaddi; Arrigo Fg Cicero; Giovanni Gambaro
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-07-06

8.  Preclinical and clinical evidence of nephro- and cardiovascular protective effects of glycosaminoglycans.

Authors:  Arrigo F Cicero; Sibel Ertek
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

9.  Laminin β2 variants associated with isolated nephropathy that impact matrix regulation.

Authors:  Yamato Kikkawa; Taeko Hashimoto; Keiichi Takizawa; Seiya Urae; Haruka Masuda; Masumi Matsunuma; Yuji Yamada; Keisuke Hamada; Motoyoshi Nomizu; Helen Liapis; Masataka Hisano; Yuko Akioka; Kenichiro Miura; Motoshi Hattori; Jeffrey H Miner; Yutaka Harita
Journal:  JCI Insight       Date:  2021-03-22

Review 10.  Sulodexide therapy for the treatment of diabetic nephropathy, a meta-analysis and literature review.

Authors:  Rui Li; Jing Xing; Xaojing Mu; Hui Wang; Lei Zhang; Yu Zhao; Yu Zhang
Journal:  Drug Des Devel Ther       Date:  2015-12-03       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.